Back

Association between congestion and aspirin resistance in patients with chronic coronary syndrome

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in pharmacology and pharmacotherapy Cardiovascular Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Imad Meray

lebanese italian hospital, Tyre (Lebanon)

4 More presentations in this session

Presentation thumbnail
Individual natriuretic and diuretic response in acute heart failure: insights from the PUSH-AHF pharmacological substudy
Doctor I. Beldhuis (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Real-world SGLT2i prescribing in an elderly population; a tertiary centre review
Doctor G. O Dea (Limerick, IE)
Abstract Slides Video
Presentation thumbnail
Supernormal cardiac function: exercise vs. dapagliflozin
Miss R. Vago (Debrecen, HU)
Abstract Slides Video
Presentation thumbnail
The PCSK9 targeted therapy - the best strategy to prevent cardiovascular complications in very high-risk patients in poland. Real-life data from the national health found B101 reimbursement program
Professor M. Banach (Lodz, PL)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in pharmacology and pharmacotherapy

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Clinical and ultrasound congestion in outpatients with heart failure according to renal function: prevalence and prognostic implications
thumbnail
Congress Presentation
Acute heart failure patients with diuretic resistance: who are they and prognostic implications of diuretic resistance. The experience of a general hospital
thumbnail
Congress Presentation
Impact of heart failure in acute coronary syndromes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources